Percutaneous Mechanical Circulatory Support Devices Market Global Analysis 2025 | Abbott, Medtronic, Getinge AB

Asia-Pacific was the leading geographic market and it is anticipated to be the highest revenue contributor throughout the forecast period.  Higher concentration of small scale industries in the developing countries like India and China, is expected to fuel percutaneous mechanical circulatory support devices market in this region.

The global percutaneous mechanical circulatory support devices market accounted to US$ 1,188.2 Mn in 2017 and is expected to grow at a CAGR of 12.3% during the forecast period 2018 – 2025, to account to US$  2,977.8 Mn by 2025.

Get Sample Copy of Report –

This market research report provides a comprehensive picture on “Percutaneous Mechanical Circulatory Support Devices Market”, from the global viewpoint, offering a forecast and statistic in terms of revenue during the forecast period. The report covers a descriptive analysis with detailed segmentation, complete research and development history, latest news and press releases. Furthermore, the study explains the future opportunities and a sketch of key players operating in the “Percutaneous Mechanical Circulatory Support Devices Market”.

Leading Percutaneous Mechanical Circulatory Support Devices Market Players:

  • Abbott
  • Medtronic
  • Getinge AB
  • Teleflex Incorporated
  • LivaNova PLC
  • Berlin Heart
  • Jarvik Heart, Inc.
  • CardioBridge GmbH

Detailed segmentation of the market, on the basis of Type and Application and a descriptive structure of trends of the segments and sub-segments are elaborated in the report. It also provides the market size and estimates a forecast from the year 2019 to 2025 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The report also provides exhaustive PEST analysis for all five regions after evaluating political, economic, social and technological factors effecting the Percutaneous Mechanical Circulatory Support Devices Market.

The report assists in determining and analyzing the key market players’ portfolios with information such as company profiles, components and services offered, financial information for last three years, key developments in past five years, and helps in constructing strategies to gain competitive advantage. The market payers from Percutaneous Mechanical Circulatory Support Devices Market are anticipated to gain lucrative growth opportunities in the future with the rising demand at the global level. Below mentioned is the list of few companies engaged in the Percutaneous Mechanical Circulatory Support Devices Market.

The Percutaneous Mechanical Circulatory Support Devices Market report is a combination of qualitative as well as quantitative analysis which can be broken down into 40% and 60% respectively. Market estimation and forecasts are presented in the report for the overall global market from 2019 – 2025, considering 2017 as the base year and 2019 – 2025 forecast period. Global estimation is further broken down by segments and geographies such as North America, Europe, Asia-Pacific, Middle East & Africa and South America covering major 16 countries across the mentioned regions. The qualitative contents for geographical analysis will cover market trends in each region and country which includes highlights of the key players operating in the respective region/country, PEST analysis of each region which includes political, economic, social and technological factors influencing the growth of the market.

 Purchase This Report at –


By Product

  • Intra-Aortic Balloon Pumps
  • VA-Extracorporeal Membrane Oxygenation (ECMO)
    • Oxygenators
    • Short-term Ventricular Assist Devices
    • Impella
    • TandemHeart

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Rest of APAC
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of MEA
  • South America (SAM)
    • Brazil
    • Rest of SAM

Strategic Insights

Product approval and acquisition were observed as the most adopted strategy in global percutaneous mechanical circulatory support devices industry. Few of the recent product approvals and acquisitions are listed below:

2018: Abbott received approval for the HeartMate 3 Left Ventricular Assist Device (LVAD) as a destination therapy for people living with advanced heart failure. With the approval, physicians can now offer the HeartMate 3 system to patients not eligible for a transplant who will live with their device for the rest of their lives.

2018: Teleflex Incorporated received FDA 510 (k) clearance for its Arrow AC3 Optimus intra-aortic balloon pump. The device is designed to help weakened hearts pump blood and can deliver IABP therapy to a broad range of patients, including candidates who had previously not been considered for IABP therapy.

2018: Medtronic completed acquisition of HeartWare International, Inc., a leading innovator of less-invasive, miniaturized, mechanical circulatory support technologies (MCS) for treating patients with advanced heart failure.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.


Contact Us:
Call: +1-646-491-9876
Email: [email protected]


Posted by on Thursday December 05 2019, 9:59 AM EDT. All trademarks acknowledged. Filed under Biotechnology, Diagnostics, Healthcare, Life Sciences, Manufacturing & Construction, Medical Devices, Pharmaceuticals. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in